These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3003777)

  • 1. Failure of the GABAergic drug, sodium valproate, to reduce basal plasma prolactin secretion in chronic schizophrenia.
    Monteleone P; Zontini G; Steardo L
    Psychoneuroendocrinology; 1985; 10(4):475-80. PubMed ID: 3003777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone response to sodium valproate in chronic schizophrenia.
    Monteleone P; Maj M; Iovino M; Steardo L
    Biol Psychiatry; 1986 Jun; 21(7):588-94. PubMed ID: 3085738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the gabaergic drug, sodium valproate, on prolactin secretion in normal and hyperprolactinemic subjects.
    Melis GB; Paoletti AM; Mais V; Mastrapasqua NM; Strigini F; Fruzzetti F; Guarnieri G; Gambacciani M; Fioretti P
    J Clin Endocrinol Metab; 1982 Mar; 54(3):485-9. PubMed ID: 6799535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological activation of gamma-aminobutyric acid-system blunts prolactin response to mechanical breast stimulation in puerperal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Kemeny A; Strigini F; Boldrini A; Fioretti P
    J Clin Endocrinol Metab; 1984 Jan; 58(1):201-5. PubMed ID: 6417154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the GABAergic drug, sodium valproate, on the prolactin release evoked by pharmacological stimuli in normal women.
    Melis GB; Fruzzetti F; Paoletti AM; Mais V; Beneventi F; Trimarchi G; Fioretti P
    Clin Endocrinol (Oxf); 1984 Mar; 20(3):245-52. PubMed ID: 6426828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid modulation of the gamma-aminobutyric acid-controlled inhibition of exercise-stimulated growth hormone and prolactin secretion in normal men.
    Coiro V; Volpi R; Maffei ML; Caiazza A; Caffarri G; Capretti L; Colla R; Chiodera P
    Eur J Endocrinol; 1994 Jul; 131(1):50-5. PubMed ID: 8038904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prolactin secretion during suckling: involvement of the hypothalamo-pituitary GABAergic system.
    Racagni G; Apud JA; Cocchi D; Locatelli V; Iuliano E; Casanueva F; Müller EE
    J Endocrinol Invest; 1984 Oct; 7(5):481-7. PubMed ID: 6096436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GABAergic control of prolactin release is not affected by insulin-dependent diabetes mellitus: evidence from studies with sodium valproate.
    Coiro V; Davoli C; Volpi R; Sorini E; Voltini E; Rossi G; Delsignore R; Gnudi A; Chiodera P
    Acta Diabetol Lat; 1986; 23(1):51-5. PubMed ID: 3012924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.
    de Miguel R; Romero J; Muñoz RM; García-Gil L; González S; Villanua MA; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
    Biochem Pharmacol; 1998 Nov; 56(10):1331-8. PubMed ID: 9825732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daily fluctuations in the activity of the tuberoinfundibular GABAergic system and plasma prolactin levels.
    Casanueva F; Apud JA; Masotto C; Cocchi D; Locatelli V; Racagni G; Muller E
    Neuroendocrinology; 1984 Oct; 39(4):367-70. PubMed ID: 6493448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of central nervous system-derived or circulating gamma-aminobutyric acid on prolactin secretion in the rat.
    Apud JA; Racagni G; Iuliano E; Cocchi D; Casanueva F; Müller EE
    Endocrinology; 1981 Apr; 108(4):1505-10. PubMed ID: 7472280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly.
    Orio F; Iovino M; Monteleone P; Agrusta M; Steardo L; Lombardi G
    Horm Metab Res; 1988 Nov; 20(11):701-4. PubMed ID: 2850985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of central GABAergic neurons in basal and diurnal changes of tuberoinfundibular dopaminergic neuronal activity and prolactin secretion.
    Lee TY; Pan JT
    Life Sci; 2001 Mar; 68(17):1965-75. PubMed ID: 11388699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired growth hormone response to sodium valproate in normal aging.
    Monteleone P; Iovino M; Orio F; Steardo L
    Psychopharmacology (Berl); 1987; 91(1):10-3. PubMed ID: 3029790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin control by the tubero-infundibular GABAergic system: role of anterior pituitary GABA receptors.
    Apud JA; Masotto C; Cocchi D; Locatelli V; Muller EE; Racagni G
    Psychoneuroendocrinology; 1984; 9(2):125-33. PubMed ID: 6089241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.
    Monteleone P; Maj M; Ariano MG; Iovino M; Fiorenza L; Steardo L
    Psychopharmacology (Berl); 1988; 96(2):223-6. PubMed ID: 3148149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of single or repeated estrogen administration on tuberoinfundibular GABA neurons and anterior pituitary GABA receptors: biochemical and functional studies.
    Apud JA; Cocchi D; Masotto C; Penalva A; Müller EE; Racagni G
    Brain Res; 1985 Dec; 361(1-2):146-53. PubMed ID: 3002545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P affects the GABAergic system in the hypothalamo-pituitary axis.
    Afione S; Debeljuk L; Seilicovich A; Pisera D; Lasaga M; Díaz MC; Duvilanski B
    Peptides; 1990; 11(6):1065-8. PubMed ID: 1708134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different sensitivity to sodium valproate in healthy, non-tumoral and tumoral hyperprolactinemic subjects.
    Sarnacchiaro F; Colao A; Merola B; Di Sarno A; Landi ML; Di Somma C; Ferone D; Tolino A; Lombardi G
    J Endocrinol Invest; 1997 Oct; 20(9):513-8. PubMed ID: 9413804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.
    Cowen PJ; Gadhvi H; Gosden B; Kolakowska T
    Psychopharmacology (Berl); 1985; 86(1-2):164-9. PubMed ID: 2991963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.